Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

NCT01194375 is registered in ClinicalTrials.gov with Dow Pharmaceutical Sciences as lead sponsor.

NCT NCT01194375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01194375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
Lead sponsor
Dow Pharmaceutical Sciences
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2010
Completion date
December 31, 2011
Enrollment
180 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris